• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI SuperconnectorNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Superconnector
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance
    Get the next $HLNE alert in real time by email

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide.

    Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future.

    "I am honored to join Grenova at such an exciting time in the company's journey," said Hull. "Grenova is revolutionizing the way laboratories think about and use plastics—transforming single-use mindsets into sustainable, reusable solutions. I look forward to working closely with this talented team to continue driving meaningful change."

    The addition to Grenova's team is complemented by a new round of equity capital. The funding will be used to enhance Grenova's automation portfolio, expand R&D capabilities, and grow the team to meet rising demand across global markets. The financing was led by Grenova investors, Peloton Equity and Hamilton Lane's (NASDAQ:HLNE) Impact Fund II, along with other existing investors.

    "This investment affirms confidence in our vision and the market's urgency to reduce plastic waste," said Katherine Marrs, CEO of Grenova. "With this capital and Ted Hull on the board, we're positioned to accelerate our mission to scale sustainable lab practices."

    "We are excited to continue supporting Grenova's growth," said Ted Lundberg, Peloton Equity Managing Partner and Grenova's Chairman. "We have worked with Ted Hull over the past 20 years and are thrilled to have him join Grenova. Ted brings a powerful blend of vision and experience that will help Grenova press its advantage as a category leader."

    Backed by experienced leadership, a unique and patent protected product suite, strong investor confidence, and a clear vision, Grenova is working to revolutionize laboratories worldwide.

    About Grenova

    Grenova® (grenova.com) is a sustainability company dedicated to revolutionizing the life sciences industry by drastically reducing waste through the washing and reuse of consumable plastics. Grenova empowers laboratories worldwide to adopt eco-friendly solutions that enhance operational efficiency and maximize sustainability impact. The company is committed to providing solutions that lower carbon footprints and reduce waste.

    About Peloton Equity

    Peloton Equity, LLC (pelotonequity.com) is a private equity firm focused exclusively on growth capital investments in the healthcare industry. Peloton invests in companies with between $10 million and $200 million of revenue that have the management team, market opportunity and business model to become category leaders. Peloton's investment team has invested in over 36 unique healthcare companies and has deployed over $900 million in capital.

    About Hamilton Lane

    Hamilton Lane (NASDAQ:HLNE) is one of the largest private markets investment firms globally, providing innovative solutions to institutional and private wealth investors around the world. Dedicated exclusively to private markets investing for more than 30 years, the firm currently employs approximately 740 professionals operating in offices throughout North America, Europe, Asia Pacific and the Middle East. Hamilton Lane has $956 billion in assets under management and supervision, composed of nearly $135 billion in discretionary assets and more than $821 billion in non-discretionary assets, as of December 31, 2024. For more information, please visit http://www.hamiltonlane.com or follow Hamilton Lane on LinkedIn.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20250423862292/en/

    Media Contact:

    Grenova

    Jessica Cookmeyer

    Marketing Communications Manager

    [email protected]

    Peloton

    Elizabeth Curland

    Head of Investor Relations

    [email protected]

    Get the next $HLNE alert in real time by email

    Crush Q3 2025 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $HLNE

    DatePrice TargetRatingAnalyst
    11/6/2025$165.00Neutral → Buy
    Goldman
    10/14/2025$181.00Perform → Outperform
    Oppenheimer
    10/13/2025$150.00Mkt Perform → Outperform
    Keefe Bruyette
    10/3/2025$150.00Outperform
    BMO Capital Markets
    9/18/2025$162.00Sell → Neutral
    Goldman
    5/15/2025Outperform → Perform
    Oppenheimer
    1/21/2025$186.00Perform → Outperform
    Oppenheimer
    1/6/2025$139.00Neutral → Sell
    Goldman
    More analyst ratings

    $HLNE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Hamilton Lane upgraded by Goldman with a new price target

    Goldman upgraded Hamilton Lane from Neutral to Buy and set a new price target of $165.00

    11/6/25 8:41:24 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Oppenheimer with a new price target

    Oppenheimer upgraded Hamilton Lane from Perform to Outperform and set a new price target of $181.00

    10/14/25 8:37:36 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane upgraded by Keefe Bruyette with a new price target

    Keefe Bruyette upgraded Hamilton Lane from Mkt Perform to Outperform and set a new price target of $150.00

    10/13/25 8:40:10 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    SEC Filings

    View All

    SEC Form 10-Q filed by Hamilton Lane Incorporated

    10-Q - Hamilton Lane INC (0001433642) (Filer)

    11/4/25 4:16:24 PM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    11/4/25 6:59:58 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Hamilton Lane INC (0001433642) (Filer)

    10/6/25 4:23:40 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Hamilton Lane Strengthens North America Client Solutions Team, Appointing Seven Senior Members

    CONSHOHOCKEN, Pa., Nov. 10, 2025 /PRNewswire/ -- Leading private markets investment management firm Hamilton Lane (NASDAQ:HLNE) today announced multiple senior appointments to its North American client solutions team, supporting both institutional and private wealth outreach. Beth Nardi joins as Head of U.S. Private Wealth, leading the firm's Private Wealth Solutions business, setting strategic direction and overseeing the delivery of both evergreen and traditional private markets offerings tailored to the evolving needs of high-net-worth investors and their advisors. She brings more than two decades of experience in the asset management industry, most recently serving as Head of Enterprise

    11/10/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Pa., Nov. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the second fiscal quarter ended September 30, 2025. The Company issued a full detailed presentation of its second quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on December 19, 2025 that will be paid on January 7, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fisca

    11/4/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane and Guardian Announce Long-Term Strategic Partnership

    CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a

    11/3/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    New insider Mcallister Margaret Anne claimed ownership of 59,006 shares and claimed ownership of 300,000 units of Class B Common Stock (SEC Form 3)

    3 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:03:07 PM ET
    $HLNE
    Investment Managers
    Finance

    Director Sexton O Griffith was granted 1,331 shares, increasing direct ownership by 38% to 4,852 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    9/18/25 5:01:35 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Co-Chief Executive Officer Delgado-Moreira Juan bought $1,042,832 worth of shares (8,000 units at $130.35), increasing direct ownership by 0.61% to 1,314,447 units (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/10/25 8:20:49 PM ET
    $HLNE
    Investment Managers
    Finance

    Co-Chief Executive Officer Delgado-Moreira Juan bought $105,950 worth of shares (525 units at $201.81) (SEC Form 4)

    4 - Hamilton Lane INC (0001433642) (Issuer)

    11/13/24 4:31:06 PM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Leadership Updates

    Live Leadership Updates

    View All

    Hamilton Lane and Guardian Announce Long-Term Strategic Partnership

    CONSHOHOCKEN, Pa. and NEW YORK, Nov. 3, 2025 /PRNewswire/ -- Leading private markets firm Hamilton Lane (NASDAQ:HLNE) and The Guardian Life Insurance Company of America® ("Guardian"), one of the nation's largest life insurers and a leading provider of employee benefits, today announced an innovative, long-term strategic partnership. Through this partnership, Hamilton Lane will manage Guardian's existing private equity portfolio of nearly $5 billion. Guardian will also commit to invest approximately $500 million per year in private equity for the next 10 years through Hamilton Lane. This commitment maintains Guardian's typical annual contribution to the asset class and supports its general a

    11/3/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Cosette Pharmaceuticals Appoints Jeff Neubig as Vice President, Quality and Regulatory Affairs

    -- Experienced Industry Leader to drive Cosette's Best-in-Class Quality Organization and facilitate Regulatory Approvals -- Cosette Pharmaceuticals, Inc., a U.S.-based, fully integrated, pharmaceutical company, announced today that it has appointed Jeff Neubig as Vice President, Quality and Regulatory Affairs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250630266171/en/Jeff Neubig, VP, Quality & Regulatory Affairs, Cosette Pharmaceuticals In this critical role, Jeff will lead Cosette's best-in-class quality and regulatory affairs organizations, maintaining the company's rigorous quality standards and further establishing Co

    6/30/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Grenova Secures New Investment; Appoints Life Sciences Veteran to the Board

    Grenova, Inc., a Virginia-based innovator in sustainable laboratory technologies, today announced two significant milestones for the company: the appointment of Ted Hull to Grenova's board, and the successful completion of a new round of growth equity capital. These developments support Grenova's strategic vision to drive innovation, expand automation capabilities, and deliver transformative solutions to laboratories worldwide. Ted Hull brings over 30 years of experience in the life sciences industry, including as a clinical lab CEO for the last 20+ years. In his role at Grenova, Mr. Hull is set to provide strategic leadership and to play a pivotal role in shaping the company's future. "I

    4/23/25 8:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Financials

    Live finance-specific insights

    View All

    HAMILTON LANE INCORPORATED REPORTS SECOND QUARTER FISCAL 2026 RESULTS

    CONSHOHOCKEN, Pa., Nov. 4, 2025 /PRNewswire/ -- Leading private markets asset management firm Hamilton Lane Incorporated (NASDAQ:HLNE) today reported its results for the second fiscal quarter ended September 30, 2025. The Company issued a full detailed presentation of its second quarter fiscal 2026 results, which can be accessed on the Company's Shareholders website at https://shareholders.hamiltonlane.com/. Dividend Hamilton Lane has declared a quarterly dividend of $0.54 per share of Class A common stock to record holders at the close of business on December 19, 2025 that will be paid on January 7, 2026. The target full-year dividend of $2.16 represents a 10% increase from the prior fisca

    11/4/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Tokenized Private Credit Fund Launches on Sei Network via KAIO's Institutional-grade Infrastructure

    -       KAIO has been leading the tokenization of major institutional funds, expanding crypto-native access to regulated money markets and alternative investment strategies -       The tokenization of Hamilton Lane SCOPE Fund on Sei's DeFi optimized design is expected to enhance accessibility for the fund's investors ABU DHABI, UAE, Oct. 15, 2025 /PRNewswire/ -- KAIO, the leading fully onchain infrastructure for regulated real-world assets (RWAs), today announced the expansion of its tokenized fund offerings on the Sei Network by bringing access to Hamilton Lane's (NASDAQ:HLNE) Senior Credit Opportunities Fund ("SCOPE") onchain, via HL SCOPE Access Fund1, for institutional and accredited inv

    10/15/25 9:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    Hamilton Lane Incorporated to Announce Second Quarter Fiscal 2026 Results on November 4, 2025

    CONSHOHOCKEN, Pa., Oct. 14, 2025 /PRNewswire/ -- Hamilton Lane Incorporated (NASDAQ:HLNE) is scheduled to release financial results for the second fiscal quarter ended September 30, 2025 before the market opens on Tuesday, November 4, 2025. A copy of the earnings release and full detailed presentation will be available on the Hamilton Lane Shareholders website at https://shareholders.hamiltonlane.com/. Hamilton Lane will host a conference call via webcast at 10:00 a.m. ET on November 4 to discuss the results for the second fiscal quarter. For access to the live event via the webcast, visit Hamilton Lane's Shareholder's website by clicking here (https://shareholders.hamiltonlane.com/) at lea

    10/14/25 7:00:00 AM ET
    $HLNE
    Investment Managers
    Finance

    $HLNE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/13/24 9:56:40 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/12/24 3:55:46 PM ET
    $HLNE
    Investment Managers
    Finance

    Amendment: SEC Form SC 13G/A filed by Hamilton Lane Incorporated

    SC 13G/A - Hamilton Lane INC (0001433642) (Subject)

    11/4/24 11:53:29 AM ET
    $HLNE
    Investment Managers
    Finance